ArticleScientific reports2025
Effects of erector spinae plane block on intraoperative blood pressure variability, blood loss, and postoperative pain in transforaminal lumbar interbody fusion.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Timing Matters: A Randomized Controlled Trial Comparing Preoperative and Postoperative Erector Spinae Plane Block for Analgesia in Laparoscopic Cholecystectomy.Medicina (Kaunas, Lithuania) · 2025Trial
- Association between intraoperative blood pressure variability and postoperative complications: a narrative review.Frontiers in cardiovascular medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Erector spinae plane block (ESPB) improves recovery and reduces opioid use, while intraoperative blood pressure variability (IBPV) negatively impacts postoperative outcomes. This study evaluates ESPB's efficacy in reducing IBPV and improving perioperative outcomes in transforaminal lumbar interbody fusion (TLIF). We retrospectively analyzed TLIF patients with and without ESPB from January 2021 to June 2023. ESPB was performed under ultrasonography guidance by anesthesiologists or operators. Intraoperative arterial blood pressure was assessed. Coefficient of variation (CV) and mean arterial pressure difference (MAPD) were calculated as IBPV metrics. Secondary outcomes included blood loss, operation time, postoperative pain, morphine consumption, time to line removal, and discharge. Sixty patients (30 ESPB, 30 non-ESPB) were included, with median ages of 61.3 and 69.5 years, respectively. The ESPB cohort showed significantly lower MAPD (42.0 mmHg vs. 47.1 mmHg, p = 0.02), CV (13.0% vs. 14.7%, p = 0.01), blood loss (268.3 mL vs. 426.7 mL, p < 0.01), and blood loss per level (105.1 mL vs. 157.6 mL, p = 0.02). ESPB also reduced pain in the recovery room (4.7 vs. 6.7, p < 0.01) and on postoperative day 1 (2.3 vs. 2.8, p < 0.01) and accelerated nutritional recovery (1.7 days vs. 3.0 days, p < 0.01). The only complication was observed in the non-ESPB group. ESPB significantly reduced IBPV, blood loss, and postoperative pain in TLIF. It also resulted in lower morphine consumption and earlier mobilization, though these differences did not reach statistical significance. No ESPB-related complications were observed, supporting its safety and its role as an effective component of perioperative management in spine surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.